Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/3597
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBasheer, Shamnad-
dc.date.accessioned2009-03-31T05:21:59Z-
dc.date.available2009-03-31T05:21:59Z-
dc.date.issued2006-09-
dc.identifier.issn0971-7544-
dc.identifier.urihttp://hdl.handle.net/123456789/3597-
dc.description334-358en_US
dc.description.abstractIf the patented gene is not absolutely essential for use by a downstream researcher, in that there are substitutes available to work with or ways in which the patent in question could be circumvented, clearly the patented gene will not block the downstream researcher. In this sense, while the first part of the title, “Block Me Not,” expresses the blocking concern in general (the thousand-mile journey), the latter part, “How ‘Essential’ Are Patented Genes?” is the more specific question that this article seeks to address (the first step in this long and arduous journey)en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.sourceJIPR Vol.11(5) [September 2006]en_US
dc.subjectGene patentsen_US
dc.subjectrestricted accessen_US
dc.subjectbiopharmaceuticalen_US
dc.titleBlock Me Not: How “Essential” are Patented Genesen_US
dc.typeArticleen_US
Appears in Collections:JIPR Vol.11(5) [September 2006]

Files in This Item:
File Description SizeFormat 
JIPR 11(5) 334-358.pdf261.65 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.